Malignant glaucoma after XEN45 implant
Minimally invasive glaucoma surgery for chronic open-angle glaucoma treatment tries to reduce the amount of chronic topical drug treatment, delaying invasive glaucoma surgery and diminishing the number of surgical complications. XEN45 uses subconjunctival drainage in order to reduce intraocular pres...
Gespeichert in:
| Veröffentlicht in: | Archivos de la Sociedad Española de Oftalmología (English ed.) 2019-03, Vol.94 (3), p.134-137 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 137 |
|---|---|
| container_issue | 3 |
| container_start_page | 134 |
| container_title | Archivos de la Sociedad Española de Oftalmología (English ed.) |
| container_volume | 94 |
| creator | Montolío Marzo, S Lanzagorta Aresti, A Davó Cabrera, J M Alfonso Muñóz, E A Piá Ludeña, J V Palacios Pozo, E |
| description | Minimally invasive glaucoma surgery for chronic open-angle glaucoma treatment tries to reduce the amount of chronic topical drug treatment, delaying invasive glaucoma surgery and diminishing the number of surgical complications. XEN45 uses subconjunctival drainage in order to reduce intraocular pressure. The report is presented of a patient following phacoemulsification, intraocular lens implantation and XEN45 implant. After four days acute malignant glaucoma was observed, with stage 3 athalamia requiring pars plana vitrectomy and secondary Ahmed valve implantation. The lower rate of complications due to minimally invasive glaucoma surgery has increased its use. Nevertheless, it is not free of severe adverse events, even requiring a multidisciplinary approach as in our malignant glaucoma report. |
| doi_str_mv | 10.1016/j.oftal.2018.10.023 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2159984831</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2159984831</sourcerecordid><originalsourceid>FETCH-LOGICAL-p126t-9db15f850f57775d6bc8010ce8d54eca7b844c55999542884a4f4a036b32f63e3</originalsourceid><addsrcrecordid>eNo1T8tKw0AUHQSxpfYLBMlK3CTO687cWUqpVai6UXAXJpOZkjJpYiZZ-PcGrGdz4J4H9xByw2jBKFMPx6ILo40FpwznS0G5uCBLzrTIQRu5IOuUjnQGcjAorshCUNBIlVmSu1cbm8PJnsbsEO3kutZmNox-yL62bxKypu3jLF6Ty2Bj8uszr8jn0_Zj85zv33cvm8d93jOuxtzUFYOAQANoraFWlUPKqPNYg_TO6gqldADGGJAcUVoZpKVCVYIHJbxYkfu_3n7oviefxrJtkvNx_sF3Uyo5m7MoUbDZenu2TlXr67IfmtYOP-X_NvELySdOZA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2159984831</pqid></control><display><type>article</type><title>Malignant glaucoma after XEN45 implant</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Montolío Marzo, S ; Lanzagorta Aresti, A ; Davó Cabrera, J M ; Alfonso Muñóz, E A ; Piá Ludeña, J V ; Palacios Pozo, E</creator><creatorcontrib>Montolío Marzo, S ; Lanzagorta Aresti, A ; Davó Cabrera, J M ; Alfonso Muñóz, E A ; Piá Ludeña, J V ; Palacios Pozo, E</creatorcontrib><description>Minimally invasive glaucoma surgery for chronic open-angle glaucoma treatment tries to reduce the amount of chronic topical drug treatment, delaying invasive glaucoma surgery and diminishing the number of surgical complications. XEN45 uses subconjunctival drainage in order to reduce intraocular pressure. The report is presented of a patient following phacoemulsification, intraocular lens implantation and XEN45 implant. After four days acute malignant glaucoma was observed, with stage 3 athalamia requiring pars plana vitrectomy and secondary Ahmed valve implantation. The lower rate of complications due to minimally invasive glaucoma surgery has increased its use. Nevertheless, it is not free of severe adverse events, even requiring a multidisciplinary approach as in our malignant glaucoma report.</description><identifier>EISSN: 2173-5794</identifier><identifier>DOI: 10.1016/j.oftal.2018.10.023</identifier><identifier>PMID: 30578069</identifier><language>eng ; spa</language><publisher>Spain</publisher><subject>Aged ; Female ; Glaucoma - etiology ; Glaucoma Drainage Implants - adverse effects ; Humans ; Postoperative Complications - etiology</subject><ispartof>Archivos de la Sociedad Española de Oftalmología (English ed.), 2019-03, Vol.94 (3), p.134-137</ispartof><rights>Copyright © 2018 Sociedad Española de Oftalmología. Publicado por Elsevier España, S.L.U. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30578069$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Montolío Marzo, S</creatorcontrib><creatorcontrib>Lanzagorta Aresti, A</creatorcontrib><creatorcontrib>Davó Cabrera, J M</creatorcontrib><creatorcontrib>Alfonso Muñóz, E A</creatorcontrib><creatorcontrib>Piá Ludeña, J V</creatorcontrib><creatorcontrib>Palacios Pozo, E</creatorcontrib><title>Malignant glaucoma after XEN45 implant</title><title>Archivos de la Sociedad Española de Oftalmología (English ed.)</title><addtitle>Arch Soc Esp Oftalmol (Engl Ed)</addtitle><description>Minimally invasive glaucoma surgery for chronic open-angle glaucoma treatment tries to reduce the amount of chronic topical drug treatment, delaying invasive glaucoma surgery and diminishing the number of surgical complications. XEN45 uses subconjunctival drainage in order to reduce intraocular pressure. The report is presented of a patient following phacoemulsification, intraocular lens implantation and XEN45 implant. After four days acute malignant glaucoma was observed, with stage 3 athalamia requiring pars plana vitrectomy and secondary Ahmed valve implantation. The lower rate of complications due to minimally invasive glaucoma surgery has increased its use. Nevertheless, it is not free of severe adverse events, even requiring a multidisciplinary approach as in our malignant glaucoma report.</description><subject>Aged</subject><subject>Female</subject><subject>Glaucoma - etiology</subject><subject>Glaucoma Drainage Implants - adverse effects</subject><subject>Humans</subject><subject>Postoperative Complications - etiology</subject><issn>2173-5794</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1T8tKw0AUHQSxpfYLBMlK3CTO687cWUqpVai6UXAXJpOZkjJpYiZZ-PcGrGdz4J4H9xByw2jBKFMPx6ILo40FpwznS0G5uCBLzrTIQRu5IOuUjnQGcjAorshCUNBIlVmSu1cbm8PJnsbsEO3kutZmNox-yL62bxKypu3jLF6Ty2Bj8uszr8jn0_Zj85zv33cvm8d93jOuxtzUFYOAQANoraFWlUPKqPNYg_TO6gqldADGGJAcUVoZpKVCVYIHJbxYkfu_3n7oviefxrJtkvNx_sF3Uyo5m7MoUbDZenu2TlXr67IfmtYOP-X_NvELySdOZA</recordid><startdate>201903</startdate><enddate>201903</enddate><creator>Montolío Marzo, S</creator><creator>Lanzagorta Aresti, A</creator><creator>Davó Cabrera, J M</creator><creator>Alfonso Muñóz, E A</creator><creator>Piá Ludeña, J V</creator><creator>Palacios Pozo, E</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201903</creationdate><title>Malignant glaucoma after XEN45 implant</title><author>Montolío Marzo, S ; Lanzagorta Aresti, A ; Davó Cabrera, J M ; Alfonso Muñóz, E A ; Piá Ludeña, J V ; Palacios Pozo, E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p126t-9db15f850f57775d6bc8010ce8d54eca7b844c55999542884a4f4a036b32f63e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; spa</language><creationdate>2019</creationdate><topic>Aged</topic><topic>Female</topic><topic>Glaucoma - etiology</topic><topic>Glaucoma Drainage Implants - adverse effects</topic><topic>Humans</topic><topic>Postoperative Complications - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Montolío Marzo, S</creatorcontrib><creatorcontrib>Lanzagorta Aresti, A</creatorcontrib><creatorcontrib>Davó Cabrera, J M</creatorcontrib><creatorcontrib>Alfonso Muñóz, E A</creatorcontrib><creatorcontrib>Piá Ludeña, J V</creatorcontrib><creatorcontrib>Palacios Pozo, E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Archivos de la Sociedad Española de Oftalmología (English ed.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Montolío Marzo, S</au><au>Lanzagorta Aresti, A</au><au>Davó Cabrera, J M</au><au>Alfonso Muñóz, E A</au><au>Piá Ludeña, J V</au><au>Palacios Pozo, E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Malignant glaucoma after XEN45 implant</atitle><jtitle>Archivos de la Sociedad Española de Oftalmología (English ed.)</jtitle><addtitle>Arch Soc Esp Oftalmol (Engl Ed)</addtitle><date>2019-03</date><risdate>2019</risdate><volume>94</volume><issue>3</issue><spage>134</spage><epage>137</epage><pages>134-137</pages><eissn>2173-5794</eissn><abstract>Minimally invasive glaucoma surgery for chronic open-angle glaucoma treatment tries to reduce the amount of chronic topical drug treatment, delaying invasive glaucoma surgery and diminishing the number of surgical complications. XEN45 uses subconjunctival drainage in order to reduce intraocular pressure. The report is presented of a patient following phacoemulsification, intraocular lens implantation and XEN45 implant. After four days acute malignant glaucoma was observed, with stage 3 athalamia requiring pars plana vitrectomy and secondary Ahmed valve implantation. The lower rate of complications due to minimally invasive glaucoma surgery has increased its use. Nevertheless, it is not free of severe adverse events, even requiring a multidisciplinary approach as in our malignant glaucoma report.</abstract><cop>Spain</cop><pmid>30578069</pmid><doi>10.1016/j.oftal.2018.10.023</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 2173-5794 |
| ispartof | Archivos de la Sociedad Española de Oftalmología (English ed.), 2019-03, Vol.94 (3), p.134-137 |
| issn | 2173-5794 |
| language | eng ; spa |
| recordid | cdi_proquest_miscellaneous_2159984831 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Aged Female Glaucoma - etiology Glaucoma Drainage Implants - adverse effects Humans Postoperative Complications - etiology |
| title | Malignant glaucoma after XEN45 implant |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T00%3A01%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Malignant%20glaucoma%20after%20XEN45%20implant&rft.jtitle=Archivos%20de%20la%20Sociedad%20Espa%C3%B1ola%20de%20Oftalmolog%C3%ADa%20(English%20ed.)&rft.au=Montol%C3%ADo%20Marzo,%20S&rft.date=2019-03&rft.volume=94&rft.issue=3&rft.spage=134&rft.epage=137&rft.pages=134-137&rft.eissn=2173-5794&rft_id=info:doi/10.1016/j.oftal.2018.10.023&rft_dat=%3Cproquest_pubme%3E2159984831%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2159984831&rft_id=info:pmid/30578069&rfr_iscdi=true |